A Resource for Healthcare and Social Services Professionals
Words Matter
Words to use and avoid when talking about addiction.
Initiation of Brixadi® Extended-Release Injectable Buprenorphine for Opioid Use Disorder
Guidance for starting a patient on Brixadi® extended-release injectable buprenorphine for the treatment of opioid use disorder. This is not meant to replace clinical decision-making.
Visit webpage
Initiation of Naltrexone for Alcohol Use Disorder
Guidance for starting a patient on naltrexone for the treatment of alcohol use disorder. This is not meant to replace clinical decision-making.
Download file
Initiation of Naltrexone for Opioid Use Disorder
Guidance for starting a patient on long-acting injectable naltrexone for the treatment of opioid use disorder. This is not meant to replace clinical decision-making.
Download file
Initiation of Sublocade® Extended-Release Injectable Buprenorphine for Opioid Use Disorder
Guidance for starting a patient on Sublocade® extended-release injectable buprenorphine for the treatment of opioid use disorder. This is not meant to replace clinical decision-making.
Visit webpage
Initiation of Transmucosal Buprenorphine for Opioid Use Disorder
Guidance for starting a patient on transmucosal buprenorphine for the treatment of opioid use disorder. This is not meant to replace clinical decision-making.
Download file
Pain Management While on Buprenorphine for Opioid Use Disorder
Guidance for managing acute and chronic pain in patients already on buprenorphine for opioid use disorder. This is not meant to replace clinical decision-making.
Download file
Pain Management While on Naltrexone
Guidance for managing acute (anticipated or unanticipated) or chronic pain in patients already on naltrexone. This is not meant to replace clinical decision-making.
Download file
Brixadi® Dosing Conversion Tables
Suggested Brixadi® corresponding dosage for patients transitioning from daily sublingual buprenorphine or monthly Sublocade® treatment to monthly or weekly Brixadi® treatment. Tables show the suggested corresponding Brixadi® dose based on current sublingual buprenorphine or Sublocade® dosage.
Visit webpage
Buprenorphine Start Guide for Patients: A Guide for Patients Beginning Buprenorphine
This is a resource on conducting a buprenorphine community initiation that can be given out to patients.
Checklist Prior to Buprenorphine-Naloxone Initiation
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 27-28.
Visit webpage
Checklist Prior to Monthly Buprenorphine Injection
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 45-46.
Visit webpage
Checklist Prior to Naltrexone Initiation
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 55-56.
Visit webpage
COWS Scale Opioid Withdrawal Record Induction Form
Download file
DSM-5 Checklist of Diagnostic Criteria: Opioid Use Disorder
Download file
Novel Naloxone Distribution Strategies
This document outlines potential strategies to increase patient access to nasal naloxone by serving as a guide for administrators, healthcare providers, and non-medical providers attempting to create reimbursable streams for naloxone.
Download file
Patient Medication Guide for Injectable Naltrexone (Vivitrol)
Visit webpage
Perioperative Management
This document gives management guidelines for patients maintained on buprenorphine who are scheduled for surgery or other procedures.
Download file
Transfer Guidelines for Methadone to Buprenorphine or Buprenorphine to Naltrexone Transition
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 33-36.
Visit webpage
Consent for Release of Information (CFR 42)
Consent for Treatment with Disulfiram
Consent for Treatment with Injectable Buprenorphine
Consent for Treatment with Naltrexone
Sample OBAT Treatment Agreement
Transmucosal Buprenorphine Consent Form
Buprenorphine Initiation Note
Download file
Initial Screening Note Template
Download file
OBAT Nursing Follow-up Note
Example of an OBAT nursing follow-up note used for ongoing assessment of patients engaged in treatment. This template includes documentation of medications for addiction treatment including injectable buprenorphine. This sample visit documentation is meant to serve as a guide.
Download file
OBAT Nursing Intake Note
Example of an OBAT nursing intake note used for comprehensive assessment of new patients. This sample visit documentation is meant to serve as a guide.
Download file
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.